Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Sensus Healthcare Inc (NASDAQ: SRTS) was $5.08 for the day, up 3.04% from the previous closing price of $4.93. In other words, the price has increased by $3.04 from its previous closing price. On the day, 63240.0 shares were traded. SRTS stock price reached its highest trading level at $5.1011 during the session, while it also had its lowest trading level at $4.83.
Ratios:
Our analysis of SRTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.49 and its Current Ratio is at 9.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Alliance Global Partners Upgraded its Neutral to Buy on August 10, 2020, whereas the target price for the stock was revised from $2.40 to $4.25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 20 ’24 when Heinrich John sold 15,227 shares for $6.24 per share. The transaction valued at 95,016 led to the insider holds 59,940 shares of the business.
Heinrich John sold 4,773 shares of SRTS for $28,399 on May 17 ’24. The Director now owns 75,167 shares after completing the transaction at $5.95 per share. On Sep 14 ’23, another insider, Sardano Joseph C, who serves as the CHIEF EXECUTIVE OFFICER of the company, bought 10,000 shares for $2.88 each. As a result, the insider paid 28,773 and bolstered with 1,175,293 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRTS now has a Market Capitalization of 83110992 and an Enterprise Value of 69955576. As of this moment, Sensus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.79, and their Forward P/E ratio for the next fiscal year is 10.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.63 while its Price-to-Book (P/B) ratio in mrq is 1.63. Its current Enterprise Value per Revenue stands at 2.21 whereas that against EBITDA is 12.239.
Stock Price History:
The Beta on a monthly basis for SRTS is 1.01, which has changed by 0.60443044 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, SRTS has reached a high of $6.55, while it has fallen to a 52-week low of $1.79. The 50-Day Moving Average of the stock is 2.14%, while the 200-Day Moving Average is calculated to be 45.63%.
Shares Statistics:
SRTS traded an average of 550.45K shares per day over the past three months and 130760 shares per day over the past ten days. A total of 16.37M shares are outstanding, with a floating share count of 13.27M. Insiders hold about 19.05% of the company’s shares, while institutions hold 15.01% stake in the company. Shares short for SRTS as of 1718323200 were 390352 with a Short Ratio of 0.71, compared to 1715731200 on 437415. Therefore, it implies a Short% of Shares Outstanding of 390352 and a Short% of Float of 2.6300002.
